What You Should Know:
- Cleveland Clinic and Dyania Health have announced a collaboration to integrate Dyania's Synapsis™ AI platform across Cleveland Clinic’s clinical research enterprise.
- The partnership, which follows successful pilot programs in cardiology, oncology, and neurology, aims to accelerate clinical trial recruitment by using medically trained large language models (LLMs) to speed up and scale patient identification for research studies. The ultimate goal is to provide more
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
Virtual Patients: How AI Simulation Is Revolutionizing Clinical Trials and Drug Development
The most consequential shift in modern medicine isn’t happening inside hospitals or biotech labs. It’s happening inside medical simulation labs / training centers.
Drug development has long been marked by high costs, inefficiency, and human trial-and-error. Indeed, the cost of developing a single therapeutic exceeds $2.6 billion according to the Tufts Center for the Study of Drug Development. Much of this expense can be attributed to the clinical trial process.
Clinical trials are a
Read More
New Vivalink Survey Finds Nearly 90% of Americans Open to Remote Clinical Trials
What You Should Know:
- A new survey shows that remote clinical trials are not just a convenient option but a key factor in whether people choose to participate in research at all.
- The survey, conducted by digital healthcare solutions provider Vivalink, found that nearly 90% of Americans are open to participating in fully remote trials, signaling a major shift in patient expectations.
A Clear Preference for Virtual Trials
The survey, which polled over 200 U.S. adults,
Read More
How Sensor Technology Is Transforming Clinical Trials
Clinical trials are the foundation of drug development, generating life-saving medicines for the betterment of society. But trials can be arduous, lengthy, and expensive for patients, sites, and sponsors, particularly in neurological disease trials, where phase III trials cost up to $370 million, last 7.9 years, and face a 95% failure rate among drug candidates 1,2,3. Moreover, traditional site-based data collection methods do not capture the complete picture of how patients are affected by
Read More
Unlocking the Power of Genomics in Clinical Trials: A Precision Medicine Data Imperative
As precision medicine continues to reshape the future of healthcare, clinical trials are evolving from one-size-fits-all studies into highly targeted investigations driven by genomics and biomarker-based insights. These trials not only test therapeutic efficacy but also help identify which patients are most likely to benefit, reducing trial-and-error in treatment and transforming hope into more predictable outcomes. With nearly half a million clinical trials underway globally, the potential to
Read More
Navigating Clinical Trials: Physicians Face Major Hurdles in Accessing Innovative Treatments
What You Should Know:
- myTomorrows, a global health technology company connecting patients and physicians with pre-approval treatments, published a new data report, "Searching for solutions: How physicians navigate trial access and technology."
- Based on a survey of 100 U.S.-based healthcare professionals, the report reveals that 61% of physicians find the process of identifying and accessing relevant clinical trials difficult, and 72% specifically find clinical trial
Read More
Ryght Partners w/ Emory Cancer Institute for AI-powered Clinical Trials
What You Should Know:
- Ryght AI, a provider of real-time generative AI healthcare technology for clinical research, today announced that the prestigious Winship Cancer Institute of Emory University has joined its unique Ryght Research Network.
- The global network creates an AI digital twin of every research site worldwide, allowing distinguished academic institutions like Winship to leverage Ryght's AI platform and applications to revolutionize clinical trial processes and
Read More
Quilt Health Raises $6M to Modernize Clinical Trial Access for Complex Diseases
What You Should Know:
- Quilt Health, a digital health company dedicated to bridging gaps in treatment access for complex diseases secures $6M in seed funding round, bringing its total funding to $8M. The round was led by MaC Venture Capital and Underscore Ventures, with participation from Meridian Street Capital, BoxGroup, Watershed VC, and Coalition Operators.
- Founded with an initial focus on sickle cell disease, the company plans to use the new capital to rapidly expand into
Read More
Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton
What You Should Know:
- Robotics startup Wandercraft has begun clinical trials for its new Personal Exoskeleton.
- Founded by Nicolas Simon, whose siblings face mobility challenges from Charcot-Marie-Tooth disease, Wandercraft aims to help individuals with spinal cord injuries, stroke, and other severe neuromuscular disorders stand and walk again using advanced robotics and artificial intelligence.
From Rehabilitation Tool to Personal Mobility
Wandercraft is already known
Read More
Flatiron Health and Massive Bio Partner to Improve Clinical Trial Enrollment
What You Should Know:
- Flatiron Health, a healthtech company focused on transforming clinical research through technology that integrates research into everyday care, has announced a strategic partnership with Massive Bio, a global leader in using artificial intelligence to streamline patient identification and recruitment for clinical trials.
- The partnership aims to expand patient identification capabilities and improve clinical trial enrollment across the U.S.
Enhance
Read More
